Akoya Biosciences Inc (AKYA)
2.14
+0.02
(+0.94%)
USD |
NASDAQ |
Nov 22, 12:23
Akoya Biosciences Profit Margin (Quarterly): -55.98% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -55.98% |
| June 30, 2024 | -56.76% |
| March 31, 2024 | -128.0% |
| December 31, 2023 | -40.78% |
| September 30, 2023 | -51.22% |
| June 30, 2023 | -88.44% |
| March 31, 2023 | -87.82% |
| December 31, 2022 | -88.95% |
| September 30, 2022 | -94.80% |
| June 30, 2022 | -97.77% |
| Date | Value |
|---|---|
| March 31, 2022 | -97.07% |
| December 31, 2021 | -109.4% |
| September 30, 2021 | -86.21% |
| June 30, 2021 | -42.56% |
| March 31, 2021 | -66.18% |
| December 31, 2020 | -44.11% |
| September 30, 2020 | -43.04% |
| June 30, 2020 | -53.56% |
| March 31, 2020 | -19.44% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-128.0%
Minimum
Mar 2024
-19.44%
Maximum
Mar 2020
-71.16%
Average
-66.18%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 4.73% |
| Azenta Inc | -2.93% |
| Harvard Bioscience Inc | -21.86% |
| Bionano Genomics Inc | -728.6% |
| Singular Genomics Systems Inc | -4.14K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -157.2% |
| Return on Assets | -36.87% |
| Return on Invested Capital | -52.65% |
| Gross Profit Margin (Quarterly) | 62.32% |
| Operating Margin (Quarterly) | -39.45% |
| Return on Net Operating Assets | -64.85% |